%0 Journal Article
%A Morán, Alberto
%A García-Aranda, Carmen
%A Díaz-López, Antonio
%A Iniesta Serrano, María Pilar
%A Juan Chocano, María Del Carmen De
%A Sánchez Pernaute, Andrés
%A Torres García, Antonio José
%A Díaz-Rubio García, Eduardo
%A Balibrea Cantero, José Luis
%A Benito De Las Heras, Manuel R.
%T Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer
%D 2005
%@ 1021-335X
%U https://hdl.handle.net/20.500.14352/116227
%X The main aim of this study was to evaluate the clinical relevance of Gelatinases in colorectal cancer (CRC). Ninety-five CRCs and their paired normal tissues were investigated to detect total levels of MMP-9, MMP-2, and the tissue inhibitors TIMP-1 and TIMP-2. Also, pro-MMP and MMP activity, and potential associations with clinical parameters were estimated. MMP-9, MMP-2 and TIMP-1 levels were greater in CRCs than in normal tissues, differences being significant for MMP-9 and TIMP-1. However, TIMP-2 showed significantly lower levels in tumour samples. Moreover, significant differences in the state of activation between gelatinases were found. TIMP-1 low levels were significantly associated with poor clinical outcome of patients. According to these data, different roles have to be attributed to MMP-2 and MMP-9 in CRC progression. Moreover, TIMP-1 level evaluation emerges as the main prognostic factor in relation to Gelatinases A and B activity in CRC.
%~